Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COMPANION DIAGNOSTICS AGREEMENT BETWEEN CLOVIS ONCOLOGY, INC. AND ROCHE MOLECULAR SYSTEMS, INC.Companion Diagnostics Agreement • August 5th, 2011 • Clovis Oncology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 5th, 2011 Company Industry JurisdictionThis COMPANION DIAGNOSTICS AGREEMENT (this “Agreement”) is made and entered into as of the latest date of signature below (the “Effective Date”) by and between Clovis Oncology, Inc., a Delaware corporation, having a place of business at 2525 28th Street, Suite 100, Boulder, CO 80301 (“Clovis Oncology”) and Roche Molecular Systems, Inc., a Delaware corporation having a place of business at 4300 Hacienda Drive, Pleasanton, California 94588 (“RMS”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MASTER SERVICE AGREEMENTMaster Service Agreement • August 5th, 2011 • Clovis Oncology, Inc. • Pharmaceutical preparations • Arizona
Contract Type FiledAugust 5th, 2011 Company Industry JurisdictionThis Master Service Agreement (this “Agreement”) is effective March 23, 2010, (the “Effective Date”), between Ventana Medical Systems, Inc., 1910 E. Innovation Park Drive, Tucson, AZ 85755 United States (“Ventana”), and Clovis Oncology, Inc., 2525 28th Street, Suite 180, Boulder, CO 80301 (“Clovis”).